Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 1836 News Items found Paul Marks Prize Honors Young Investigators for Promising Cancer Research Thursday, March 1, 2012 Memorial Sloan Kettering Cancer Center feted three gifted young investigators for their insightful contributions to cancer research in a public symposium on December 1, 2011. Ping Chi Named to Geoffrey Beene Junior Faculty Chair Thursday, March 1, 2012 Medical oncologist Ping Chi has been named an incumbent of a Geoffrey Beene Junior Faculty Chair, a position designed to provide funding to outstanding young researchers at a crucial early stage in their careers. Study Reveals How Some Skin Tumors May Evade New Therapy Thursday, March 1, 2012 Research led by investigators at Memorial Sloan Kettering has identified a previously unknown mechanism of resistance to the newly approved melanoma drug vemurafenib. In the Lab Studies Show How Certain Gene Mutations May Promote Cancer Wednesday, February 15, 2012 Two Memorial Sloan Kettering studies provide new clues about genetic mutations that affect cell behavior and play a role in several types of cancer. Q&A 3D Shape of an Ion Channel Revealed Wednesday, February 8, 2012 Structural biologist Stephen Long talks about how his team used x-ray crystallography to discover the structure of an ion channel called K2P1. In the News Memorial Sloan Kettering Made Major Contributions to Cancer Advances in 2011 Monday, February 6, 2012 Two of the year's top five cancer research advances cited by the American Society of Clinical Oncology were led by Memorial Sloan Kettering investigators. In the Lab Researchers Shed Light on Possible Cause of Infections in Cancer Patients Friday, January 20, 2012 Infections are a common cause of complications in cancer patients. Now a Memorial Sloan Kettering research team finds that a commonly prescribed antibiotic could increase susceptibility to a bacterial infection. In the Clinic Bone Scan Index May Help Determine Response to Prostate Cancer Treatment Friday, January 13, 2012 Researchers at Memorial Sloan Kettering have shown the usefulness of a scale called the Bone Scan Index (BSI) for determining whether some prostate cancer patients are responding to therapy. Honors Memorial Sloan Kettering Researchers Appointed to Stand Up To Cancer Melanoma “Dream Team” Wednesday, December 14, 2011 Five Memorial Sloan Kettering scientists have been appointed to a new research team dedicated to identifying targets for therapies to treat a certain form of melanoma. In the Lab Findings Could Lead to the Development of a New Painkiller Tuesday, December 13, 2011 Scientists have generated a compound that could potentially be used to create a new type of pain medication that may prevent the side effects of currently available painkillers. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment